NCM · Medical - Diagnostics & Research

INBS (INBS) Stock

$1.59 -7.56% NCM: INBS Healthcare

Valuation

MetricValue
Price$1.59
Market Cap$1.03M
P/E Ratio-0.14
P/B Ratio0.61
P/S Ratio0.47
EPS (TTM)$-20.00
52-Week High$24.90
52-Week Low$1.59
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-366.67%
ROA-137.50%
ROCE-366.67%
Gross Margin-366.67%
Operating Margin-366.67%
Net Margin-2.97%
Debt/Equity0.21
Current Ratio0.80

Annual Financials (USD)

Metric20212022202320242025
Revenue$2.0M$0$1.0M$3.0M$3.0M
Operating Profit$-6.0M$-8.0M$-13.0M$-10.0M$-11.0M
Net Profit$-7.0M$-8.0M$-11.0M$-10.0M$-11.0M
EPS$-162.20$-113.30$-105.80$-63.80$-20.00
Op Margin-281.4%—-1002.1%-330.5%-348.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$22.0M$12.0M$10.0M$14.0M$8.0M
Total Liabilities$7.0M$6.0M$7.0M$6.0M$5.0M
Cash$13.0M$8.0M$2.0M$6.0M$1.0M
Borrowings$0$0$2.0M$1.0M$0

Latest News

Intelligent Bio Solutions Launches FDA Interference Study for Fingerprinting Drug Test System MT Newswires · Jun 16, 2026 Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance and Planned U.S. Market Entry GlobeNewswire · Jun 16, 2026 Intelligent Bio Solutions to Participate in Planet MicroCap Las Vegas Conference over June 16-18 GlobeNewswire · Jun 4, 2026 Intelligent Bio Solutions Commences Multi-Site Method Comparison Study for FDA 510(k) Submission GlobeNewswire · Jun 2, 2026 Intelligent Bio Solutions Reports Fiscal Third Quarter Revenue Growth of 46% Year-over-Year GlobeNewswire · May 13, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-11.0M$-3.0M$-7.0M$-10.0M$-10.0M
Investing Cash Flow$0$-1.0M$-1.0M$0$0
Financing Cash Flow$-1.0M$0$-1.0M$2.0M$0
Net Cash Flow$12.0M$-4.0M$-7.0M$5.0M$-5.0M
Free Cash Flow$-11.0M$-4.0M$-8.0M$-10.0M$-10.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-626.02%
Quick Ratio1.98
Interest Coverage—
Return 1Y-87.95%
Return 3Y-99.36%
Return 5Y-99.97%

Ownership

Insiders Held3.57%
Institutions Held8.71%
Institutions Float Held9.03%
Institutional HolderSharesReport Date
Armistice Capital, LLC130,0002026-03-31
Alyeska Investment Group, L.p.37,9562026-03-31
Geode Capital Management, LLC28,6092026-03-31
Vanguard Capital Management LLC5,8102026-03-31
Vanguard Fiduciary Trust Co3,9582026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADIL $3.33 +1.22% -1.14 $3.20M 0.00%
BCLIBrainstorm Cell Therapeutics Inc. $0.98 +6.52% -1.04 $10.81M 0.00%
BNGO $1.07 +0.94% -1.16 $12.28M 0.00%
CHEKCheck-Cap Ltd. $1.86 +1.64% -0.43 $10.88M 0.00%
HSCS $2.18 +4.81% -0.70 $4.71M 0.00%

About INBS

INBS is led by CEO Harry Simeonidis, employs 50 people, headquartered in US, publicly traded since 2020.

INBS stock trades at $1.59 with a market capitalization of $1.03M. The stock is valued at a price-to-earnings (P/E) ratio of -0.14, price-to-book of 0.61, price-to-sales of 0.47. Over the past 52 weeks the stock has ranged between $1.59 and $24.90, and currently trades 93.6% below its 52-week high.

On profitability, INBS generates a return on equity (ROE) of -366.67%, return on capital employed of -366.67%, an operating margin of -366.67%, a net profit margin of -2.97%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides